Anne Moon Crompton, PhD, Vice President, Assay Development. Dr. Moon has ten years of experience in assay development, drug discovery and cancer research. As one of the first employees of Cytokinetics, she was head of the cell-based assay group and development of novel cellular informatics tools. At Onyx Pharmaceuticals she validated molecular targets in the Ras signaling pathway, and was project manager for the oncolytic virus product program. Dr. Moon received a PhD in Molecular and Cell Biology from the University of California, Berkeley and a BA in Biology from Harvard.

Andrew G. Kirn, CPA, Vice President & Controller. Mr. Kirn has over 15 years accounting and finance experience and has held various accounting and finance positions, including Controller, Director of Corporate Accounting, and Director of Finance. He has worked in high tech industries including biotechnology, semiconductor capital equipment manufacturing, internet security and circuit board manufacturing. Positions included Division Controller for Rand McNally’s media division. Mr. Kirn holds a Bachelors of Science degree in Finance and Operations Research from the University of California, Berkeley.

Gary Potter, Head of Manufacturing, has over 23 years of biotechnology experience. Gary has an extensive experience in manufacturing (pre-clinical to commercialization) of biotechnology products. Gary has experience with numerous biotech methods and cell lines to produce clinical/commercial products. His experience ranges from static techniques to culture attached cell lines and large stirred tank bioreactors for suspension for microbial and mammalian cell lines. In addition to producing clinical/commercial products, Gary has experience designing, commissioning, starting-up, validating, and licensing manufacturing facilities. He has designed a small scale pilot plant (Creative Biomolecules), supervised the start-up, validation, and successful pre-approval inspection of two cell culture manufacturing suites (Baxter), and directed the upstream design, user requirements, construction, vender selection/equipment procurement, staffing/training, commissioning, start-up, validation, and eventual successful PAI of $140M manufacturing facility (Abgenix/Amgen). Prior to joining Jennerex, Gary has held a wide range of positions in the manufacturing organization: Operator, Supervisor, Contract Manufacturing Manager (Baxter), Director of Cell Culture/Fermentation Operations (Abgenix/Amgen), and Director of Manufacturing (Cell Genesys).

Back to Top